Venus Remedies gets marketing authorisation from Philippines, Saudi Arabia for three oncology drugs

Pharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs. In a statement, the Panchkula-based company said it has received regulatory approval from Philippines, the second largest market in the Association of Southeast Asian Nations (ASEAN) region, for chemotherapy drug paclitaxel and zoledronic acid.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news